Clinical Trial Update: Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics Study of Tolvaptan in Pediatric Congestive Heart Failure (CHF) Patients With Volume Overload [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of tolvaptan in pediatric congestive heart failure patients with vol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• tolvaptan (tolvaptan)

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Pediatric Congestive Heart Failure (CHF) Patients With Volume Overload | Phase 3 | Status: COMPLETED | Results posted: 2024-08-23